XT
PCVX icon

XTX Topco’s Vaxcyte PCVX Stock Holding History

XTX Topco’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
18,191
+3,110
+21% +$169K 0.01% 1739
2026
Q1 		$876K Sell
15,081
-180
-1% -$9.77K 0.02% 1534
2025
Q4 		$704K Buy
+15,261
New +$683K 0.02% 1310
2025
Q3 		– Sell
-41,678
Closed -$1.35M – 3095
2025
Q2 		$1.35M Buy
41,678
+27,882
+202% +$914K 0.06% 504
2025
Q1 		$521K Buy
13,796
+10,770
+356% +$861K 0.03% 1001
2024
Q4 		$248K Buy
+3,026
New +$300K 0.02% 1375
2023
Q4 		– Sell
-4,696
Closed -$239K – 1984
2023
Q3 		$239K Sell
4,696
-670
-12% -$33.1K 0.04% 899
2023
Q2 		$268K Sell
5,366
-4,363
-45% -$207K 0.05% 801
2023
Q1 		$365K Buy
+9,729
New +$413K 0.08% 499

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

XTX Topco's PCVX Position: Q2 2026 in Review

XTX Topco increased its Vaxcyte (PCVX) stake by 21% in Q2 2026, buying an estimated $169K and bringing the position to 18,191 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #1739.

XTX Topco first reported a position in PCVX in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.35M in Q2 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • XTX Topco held 18,191 shares of Vaxcyte worth $1.06M as of Q2 2026.
  • XTX Topco bought 3,110 Vaxcyte shares in Q2 2026, an estimated $169K.
  • Vaxcyte made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1739 holding.
  • XTX Topco first reported a position in Vaxcyte in Q1 2023 and has held it in 9 quarters since.
  • XTX Topco's Vaxcyte position peaked at $1.35M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.